NASDAQ

Cullinan Therapeutics, Inc. (CGEM)

♥ 527 Thanks from members

Live price chart, market sentiment, and community perspectives for Cullinan Therapeutics, Inc. (NASDAQ: CGEM).

Member Opinions and Insights

Special Briefing

How to Live for 300 Years: The Longevity Sandbox

Explore plasma cleansing, somatic organ swaps, and BCI.

Explore →
Entity and Market Metadata
Sector: HealthcareIndustry: BiotechnologyFounder: Cullinan Oncology FoundersLeadership: Anand Shah (CEO)Leadership: Jeffrey Jones (CFO)Holder: Bain Capital Life SciencesHolder: FMR LLCHolder: BlackRock Inc.ZipalertinibCLN-049Immuno-Oncology Pipeline#Cullinan Therapeutics#CGEM#Biotech#Oncology#Targeted Therapies